Creatinine

EC 200-306-6

Also known as N-amidinosarcosine.

Latest news on creatinine

24 August 2026

Sobi Japan and Asahi Kasei: Empaveli approved in Japan for C3 glomerulopathy and primary immune complex membranoproliferative glomerulonephritis

First complement inhibitor in Japan for patients aged 12+ with these rare kidney diseases; VALIANT showed 68.1% proteinuria reduction and eGFR stabilization versus placebo.